U.S. markets close in 1 hour 23 minutes
  • S&P 500

    3,637.81
    +8.16 (+0.22%)
     
  • Dow 30

    29,882.25
    +9.78 (+0.03%)
     
  • Nasdaq

    12,215.94
    +121.54 (+1.00%)
     
  • Russell 2000

    1,846.69
    +1.67 (+0.09%)
     
  • Crude Oil

    45.55
    -0.16 (-0.35%)
     
  • Gold

    1,789.20
    -22.00 (-1.21%)
     
  • Silver

    22.67
    -0.69 (-2.96%)
     
  • EUR/USD

    1.1960
    +0.0047 (+0.39%)
     
  • 10-Yr Bond

    0.8540
    -0.0240 (-2.73%)
     
  • GBP/USD

    1.3317
    -0.0039 (-0.29%)
     
  • USD/JPY

    104.0180
    -0.2320 (-0.22%)
     
  • BTC-USD

    16,721.21
    -445.44 (-2.59%)
     
  • CMC Crypto 200

    327.15
    -10.35 (-3.07%)
     
  • FTSE 100

    6,366.83
    +3.90 (+0.06%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

NanoString Technologies: Q3 Earnings Insights

Benzinga Insights
·1 min read

Shares of NanoString Technologies (NASDAQ:NSTG) were flat in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share fell 1.56% over the past year to ($0.65), which missed the estimate of ($0.60).

Revenue of $31,845,000 up by 4.06% year over year, which beat the estimate of $28,690,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 09, 2020

View more earnings on NSTG

Time: 04:30 PM

ET Webcast URL: https://www.directeventreg.com/der/validateConferenceId.action

Recent Stock Performance

Company's 52-week high was at $46.93

52-week low: $13.85

Price action over last quarter: Up 8.91%

Company Description

NanoString Technologies Inc is a biotechnology company involved in translational research and molecular diagnostics. The product portfolio is based on a novel digital molecular barcoding technology. This technology, nCounter Analysis System, uses molecular barcodes and single-molecule imaging to distinguish and count hundreds of unique transcripts in a single reaction. Geographically, it derives maximum revenue from the Americas and also has a presence in Europe and Middle East, and the Asia Pacific. Other products and services include Analysis Solutions, GeoMx Digital Spatial Profiler, Gene Expression, Vantage 3D Assays, Sample Prep, and nCounter Consumables. The system is used for performing cancer research, biomarker validation and screening, and next-generation sequencing validation.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.